A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Marijuana and its CD4 Receptors: A New HIV Treatment Strategy?
Pathway to a Cure: Cancer Drug Helps Purge HIV From Resting Cells
Life Expectancy With HIV Increases Dramatically
Undetectable Viral Load? Not Necessarily in Semen
Engineering CD8 Cells to Kill HIV in Tissues
Pathway to a Cure: Positive Results Continue for Sangamo's CCR5 Gene Therapy
Revised U.S. Guidelines: HIV Treatment is Recommended for All People Living With HIV
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailprint

December 15, 2011

Headaches, Migraines Common in People Living With HIV

Headaches affect one in two HIV-positive people, with more than one in four people living with the virus experiencing chronic migraines, according to a new University of Mississippi research paper published ahead of print in the medical journal Headache.

“This research is of interest for several reasons,” Todd Smitherman, PhD, noted in an accompanying press release. “Recent research from the U.S. Centers for Disease Control and Prevention shows that, despite the availability of medications that effectively slow disease progression, most Americans with HIV do not have the disease under control. Our study shows that patients with poorly controlled HIV/AIDS are most prone to suffer also from frequent, severe migraines at rates that far exceed those of the general population.”

The objective of the study, conducted by Smitherman and his colleagues, was to characterize headache symptoms among people living with HIV and to assess the associations between headaches and various HIV disease variables, such as CD4 cell count, viral load, length of HIV infection and use of antiretroviral (ARV) therapy.

Two hundred people living with HIV averaging 43 years old—49 percent were female, and 74 percent were African American—from an internal medicine clinic and an AIDS outreach clinic participated in a diagnostic interview and two pain-related disability assessments to evaluate and define headache characteristics and related features that are consistent with established medical classifications. The study was cross-sectional in design, meaning that volunteers were asked to recall their current or past headache symptoms, along with their HIV medical histories, during the interview and assessment visit.

According to the study’s results, 107 (53.5 percent) of the HIV-positive interview subjects reported headache symptoms. Unfortunately, the researchers did not employ a control group—consisting of demographically matched HIV-negative individuals—thus the study was not able to conclude that headache symptoms are necessarily more common among people living with HIV.

However, Smitherman and his colleagues noted that many of the headaches reported were “not your typical, run-of-the mill tension headaches.” About 27.5 percent of the study volunteers met criteria for “chronic migraine,” a rare headache condition in which a person has migraine symptoms—intense, pulsating and throbbing head pain; sensitivity to light; nausea and vomiting; blurred vision; etc.—for 15 or more days per month. In comparison, the authors suggest, only 2 percent of the general population is classified as having chronic migraines.

Severity of HIV disease—as indicated by CD4 cell counts—but not duration of HIV or number of prescribed ARV medications, was strongly associated with headache severity, frequency and disability. HIV severity also distinguished migraine from tension-type headaches. Whether there was an association between specific ARVs and headaches was not reported by the researchers.

“Problematic headache is highly prevalent among patients with HIV/AIDS, most of which conform to the [criteria] of chronic migraine,” the authors conclude. “A low frequency of identifiable secondary causes”—notably AIDS-related diseases of the central nervous system—“is likely attributable to reduced frequency of opportunistic infections in the current era of [combination ARV therapy],” they add. “Disease severity is strongly predictive of headache, highlighting the importance of physician attention to headache symptoms and of patient adherence to treatment.”

Search: headache, migraine, Smitherman, University of Mississippi, CD4 cells


Scroll down to comment on this story.

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 2 (of 2 total)    

mark, adelaide, 2012-01-10 06:44:06
the world of science has only just figured this out? Wow! i'm impressed. All the money that is wasted on studies that could be spent on combatting HIV and supporting those living with HIV to tell us this - you should have just listened to us in the first place when we told you we were getting really bad f#*king migraines - in part due to us having to read asinine articles such as this!

barry, waco,ga, 2011-12-22 09:18:12
I don't feel crazy anymore now! After going to the neurologist and undergoing several tests from mri to spinal tap, this explains my daily headaches, generally tenion in nature. Being hiv+ for 18 years and on meds for 16 years i guess that explains alot! Thank you POZ for your informative stories!

comments 1 - 2 (of 2 total)    


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    dulce_angelita
    Bronx
    New York


    RyGuy00
    Deerfield Beach
    Florida


    ToPherCE
    san diego
    California


    posattitude2011
    Williamstown,NJ
    New Jersey
Click here to join POZ Personals!
Conference Coverage

19th Conference on Retroviruses and Opportunistic Infections (CROI 2012)
Seattle, Washington
March 5 - 8, 2012


6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)
Rome, Italy
July 17 - 20, 2011


18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
Boston, MA
February 27 - March 2, 2011


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.